Most Recent
Titan paints Pentana as villain to divert from ‘brazen’ copyright theft, trial told
Car dealership software firm Pentana has accused competitor Titan of a "calculated, sustained and brazen" invasion of its rights, and argues cross-claims of misuse of market power are a distraction.
Sun Pharma defeats appeal over Otsuka’s injectable Abilify patent
The Full Federal Court has upheld a decision revoking Otsuka Pharmaceuticals’ patent extension for an injectable version of antipsychotic drug Abilify, finding the patent expired last year.
Titan accuses rival Pentana of holding customer data ‘hostage’
In a copyright and competition fight with car dealer software company Pentana that heads to trial on Monday, Titan DMS says its rival is trying to bar it from helping customers overcome a practice of holding their data "hostage”.
Regeneron, Bayer settle appeal over launch of Sandoz’s Eylea biosimilar
Biotech Regeneron and drug company Bayer have resolved their appeal of a ruling that allowed generic pharmaceutical manufacturer Sandoz to launch a version of top selling macular degeneration drug Eylea. 
Fortescue, Element Zero reach settlement in trade secrets case
After losing a fight over access to millions of seized documents, Fortescue has settled its trade secrets case against green iron company Element Zero.
Nearly Naked winemaker fends off trade mark challenge
The trademarks office has knocked back Naked Wines' opposition to an Adelaide winemaker’s Nearly Naked trademark, finding that the popular wine retailer had failed to substantiate its reputation in the industry.
Foxtel can’t knock out Tencent’s Arena Breakout trade mark
Chinese video game giant Tencent can amend a bid to register its Arena Breakout videogame trade marks, after IP Australia found only minimal overlap with Foxtel’s ‘Arena’ brand.
Momofuku appeals loss in trade mark dispute with instant noodle giant
Famed restaurant chain Momofuku has filed an appeal after losing its challenge to a trade mark of instant noodle giant Nissin Foods, a court has heard.
Suit accuses Telix of breaching licence agreement for cancer drug Zircaix
German pharmaceutical company Heidelberg Pharma has filed a lawsuit against Australian drug maker Telix alleging breach of a licence agreement for its kidney cancer diagnostic drug Zircaix. 
Light & Wonder employees can’t dodge subpoenas in Aristocrat case
A judge has signed off on subpoenas compelling employees of gaming company Light & Wonder to give evidence in a US case by Aristocrat alleging misuse of confidential information about its popular Dragon Link poker machine.